SEARCH

SEARCH BY CITATION

References

  • 1
    Grattan CE, Wallington TB, Warin RP, Kennedy CT, Bradfield JW. A serological mediator in chronic idiopathic urticaria--a clinical, immunological and histological evaluation. Br J Dermatol 1986;114:583590.
  • 2
    Mari A. Allergy-like asthma and rhinitis. A cross-sectional survey of a respiratory cohort and a diagnostic approach using the autologous serum skin test. Int Arch Allergy Immunol 2004;133:2939.
  • 3
    Brunetti L, Francavilla R, Miniello VL, Platzer MH, Rizzi D, Lospalluti ML et al. High prevalence of autoimmune urticaria in children with chronic urticaria. J Allergy Clin Immunol 2004;114:922927.
  • 4
    Du Toit G, Prescott R, Lawrence P, Johar A, Brown G, Weinberg EG et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol 2006;96:341344.
  • 5
    Guttman-Yassky E, Bergman R, Maor C, Mamorsky M, Pollack S, Shahar E. The autologous serum skin test in a cohort of chronic idiopathic urticaria patients compared to respiratory allergy patients and healthy individuals. J Eur Acad Dermatol Venereol 2007;21:3539.
  • 6
    Jang AS, Park JS, Lee JH, Park SW, Kim DJ, Park CS. Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma. Respiration 2007;74:293296.
  • 7
    Comi AL, Tedeschi A, Lorini M, Miadonna A. Novel clinical and serological aspects in non-allergic asthma. Respir Med 2007;101:25262533.
  • 8
    Tedeschi A, Comi AL, Lorini M, Tosini C, Miadonna A. Autologous serum skin test reactivity in patients with non-allergic asthma. Clin Exp Allergy 2005;35:849853.
  • 9
    Lagnado R, King AJ, Donald F, Dua HS. A protocol for low contamination risk of autologous serum drops in the management of ocular surface disorders. Br J Ophthalmol 2004;88:464465.
  • 10
    Anonymous. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003: setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components, and amending Directive 2001/83/EC. Official Journal of the European Union 2003;33:3040.
  • 11
    Anonymous. Council of Europe: Recommendation NO.R(95)15 Guide to the preparation, use and quality assurance of blood components, 13th edn. Strasbourg: Council of Europe Publishing, 2007.
  • 12
    Anonymous. Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989;44(Suppl 10):159.
  • 13
    Grattan CE. Evaluation of a proinflammatory serological mediator in chronic urticaria. MD Thesis, University of Cambridge, 1996.
  • 14
    Grattan CE, Hamon CG, Cowan MA, Leeming RJ. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol 1988;119:179183.
  • 15
    Asero R, Tedeschi A, Lorini M, Salimbeni R, Zanoletti T, Miadonna A. Chronic urticaria: novel clinical and serological aspects. Clin Exp Allergy 2001;31:11051110.
  • 16
    Asero R, Tedeschi A, Lorini M. Autoreactivity is highly prevalent in patients with multiple intolerances to NSAIDs. Ann Allergy Asthma Immunol 2002;88:468472.
  • 17
    Erbagci Z. Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity. J Dermatol 2004;31:376382.
  • 18
    Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443450.
  • 19
    Klos K, Kruszewski J, Kruszewski R, Sulek K. The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial. Pol Merkur Lekarski 2006;21:449453.
  • 20
    Simons FE, Simons KJ, Frith EM. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. J Allergy Clin Immunol 1984;73:6975.
  • 21
    Rao KS, Menon PK, Hilman BC, Sebastian CS, Bairnsfather L. Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. J Allergy Clin Immunol 1988;82:752757.
  • 22
    Wang SS, Wang SR, Chiang BN. Suppressive effects of oral ketotifen on skin responses to histamine, codeine, and allergen skin tests. Ann Allergy 1985;55:5761.
  • 23
    Simons FE, Simons KJ. Clinical pharmacology of H1-antihistamines. Clin Allergy Immunol 2002;17:141178.
  • 24
    Almind M, Dirksen A, Nielsen NH, Svendsen UG. Duration of the inhibitory activity on histamine-induced skin weals of sedative and non-sedative antihistamines. Allergy 1988;43:593596.
  • 25
    Grattan CE, O’Donnell BF, Francis DM, Niimi N, Barlow RJ, Seed PT et al. Randomized double-blind study of cyclosporin in chronic ‘idiopathic’ urticaria. Br J Dermatol 2000;143:365372.
  • 26
    Inase N, Schreck RE, Lazarus SC. Heparin inhibits histamine release from canine mast cells. Am J Physiol 1993;264:L387L390.
  • 27
    Lucio J, D’Brot J, Guo CB, Abraham WM, Lichtenstein LM, Kagey-Sobotka A et al. Immunologic mast cell-mediated responses and histamine release are attenuated by heparin. J Appl Physiol 1992;73:10931101.
  • 28
    Ahmed T, Campo C, Abraham MK, Molinari JF, Abraham WM, Ashkin D et al. Inhibition of antigen-induced acute bronchoconstriction, airway hyperresponsiveness, and mast cell degranulation by a nonanticoagulant heparin: comparison with a low molecular weight heparin. Am J Respir Crit Care Med 1997;155:18481855.
  • 29
    Bowler SD, Smith SM, Lavercombe PS. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis 1993;147:160163.
  • 30
    Fagiolo U, Cancian M, Bertollo L, Peserico A, Amadori A. Inhibitory effect of heparin on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 1999;103:11431147.
  • 31
    Kalpaklioglu AF, Demirel YS, Saryal S, Misirligil Z. Effect of pretreatment with heparin on pulmonary and cutaneous response. J Asthma 1997;34:337343.
  • 32
    Antczak-Marczak M, Kuna P. The effect of heparin on release of histamine from basophils under the influence of MCAF/MCP-I in patients with bronchial asthma. Pneumonol Alergol Pol 1997;65:581587.
  • 33
    Antczak-Marczak M, Kuna P. [The influence of heparin on histamine level in plasma during the early reaction phase of asthma]. Pol Arch Med Wewn 1997;97:714.
  • 34
    Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446452.
  • 35
    Nettis E, Dambra P, D’Oronzio L, Cavallo E, Loria MP, Fanelli M et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002;27:2931.
  • 36
    Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S. Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 2006;24:201206.
  • 37
    Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998;102:651658.
  • 38
    Bakos N, Hillander M. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol 2003;42:613615.
  • 39
    O’Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005;153:331335.
  • 40
    Piconi S, Trabattoni D, Iemoli E, Fusi ML, Villa ML, Milazzo F et al. Immune profiles of patients with chronic idiopathic urticaria. Int Arch Allergy Immunol 2002;128:5966.
  • 41
    Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, Nusem D et al. Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 2004;59:869873.
  • 42
    Hidvegi B, Nagy E, Szabo T, Temesvari E, Marschalko M, Karpati S et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003;132:177182.
  • 43
    Garmendia JV, Zabaleta M, Aldrey O, Rivera H, De Sanctis JB, Bianco NE et al. Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients. Invest Clin 2006;47:361369.
  • 44
    De Swerdt A, Van Den Keybus C, Kasran A, Cadot P, Neyens K, Coorevits L et al. Detection of basophil-activating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin Immunol 2005;116:662667.
  • 45
    Mamatha G, Balachandran C, Smitha P. Chronic idiopathic urticaria: comparison of clinical features with positive autologous serum skin test. Indian J Dermatol Venereol Leprol 2008;74:105108.
  • 46
    Asero R. Sex differences in the pathogenesis of chronic urticaria. J Allergy Clin Immunol 2003;111:425426.
  • 47
    Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, Melani L et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004;84:288290.
  • 48
    Staubach P, Onnen K, Vonend A, Metz M, Siebenhaar F, Tschentscher I et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006;212:150159.
  • 49
    Staubach P, Eckhardt-Henn A, Dechene M, Vonend A, Metz M, Magerl M et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol 2006;154:294298.
  • 50
    O’Donnell BF, O’Neill CM, Francis DM, Niimi N, Barr RM, Barlow RJ et al. Human leucocyte antigen class II associations in chronic idiopathic urticaria. Br J Dermatol 1999;140:853858.
  • 51
    Oztas P, Onder M, Gonen S, Oztas MO, Soylemezoglu O. Is there any relationship between human leucocyte antigen class II and chronic urticaria? (chronic urticaria and HLA class II). Yonsei Med J 2004;45:392395.
  • 52
    Aydogan K, Karadogan SK, Akdag I, Tunali S. HLA class I and class II antigens in Turkish patients with chronic ordinary urticaria. Clin Exp Dermatol 2006;31:424429.
  • 53
    Asero R. Chronic idiopathic urticaria: a family study. Ann Allergy Asthma Immunol 2002;89:195196.
  • 54
    Zuberbier T, Henz BM, Fiebiger E, Maurer D, Stingl G. Anti-FcepsilonRIalpha serum autoantibodies in different subtypes of urticaria. Allergy 2000;55:951954.
  • 55
    Asero R, Orsatti A, Tedeschi A, Lorini M. Autoimmune chronic urticaria associated with type 1 diabetes and Graves’ disease. J Allergy Clin Immunol 2005;115:10881089.
  • 56
    Ryhal B, DeMera RS, Shoenfeld Y, Peter JB, Gershwin ME. Are autoantibodies present in patients with subacute and chronic urticaria? J Investig Allergol Clin Immunol 2001;11:1620.
  • 57
    Leznoff A, Josse RG, Denburg J, Dolovich J. Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol 1983;119:636640.
  • 58
    Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989;84:6671.
  • 59
    Turktas I, Gokcora N, Demirsoy S, Cakir N, Onal E. The association of chronic urticaria and angioedema with autoimmune thyroiditis. Int J Dermatol 1997;36:187190.
  • 60
    Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007;12:567571.
  • 61
    Gaig P, Garcia-Ortega P, Enrique E, Richart C. Successful treatment of chronic idiopathic urticaria associated with thyroid autoimmunity. J Investig Allergol Clin Immunol 2000;10:342345.
  • 62
    Fusari A, Colangelo C, Bonifazi F, Antonicelli L. The autologous serum skin test in the follow-up of patients with chronic urticaria. Allergy 2005;60:256258.
  • 63
    Hizal M, Tuzun B, Wolf R, Tuzun Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol 2000;39:443445.
  • 64
    Baskan EB, Turker T, Gulten M, Tunali S. Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. Int J Dermatol 2005;44:993995.
  • 65
    Asero R, Lorini M, Suli C, Tedeschi A. NSAID intolerance in chronic idiopathic urticaria: a study of its relationship with histamine-releasing activity of patients’ sera. Allergol Immunopathol (Madr) 2001;29:119122.
  • 66
    Baskan EB, Tunali S, Turker T, Saricaoglu H. Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria. J Dermatolog Treat 2004;15:164168.
  • 67
    Di Gioacchino M, Di Stefano F, Cavallucci E, Verna N, Ramondo S, Paolini F et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003;24:285290.
  • 68
    Toubi E, Blant A, Kessel A, Golan TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997;52:312316.
  • 69
    O’Donnell BF, Barr RM, Black AK, Francis DM, Kermani F, Niimi N et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101106.
  • 70
    Grattan CE, Francis DM, Slater NG, Barlow RJ, Greaves MW. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992;339:10781080.
  • 71
    Pereira C, Tavares B, Carrapatoso I, Loureiro G, Faria E, Machado D et al. Low-dose intravenous gammaglobulin in the treatment of severe autoimmune urticaria. Eur Ann Allergy Clin Immunol 2007;39:237242.
  • 72
    Niimi N, Francis DM, Kermani F, O’Donnell BF, Hide M, Kobza-Black A et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria. J Invest Dermatol 1996;106:10011006.
  • 73
    Grattan CE, Walpole D, Francis DM, Niimi N, Dootson G, Edler S et al. Flow cytometric analysis of basophil numbers in chronic urticaria: basopenia is related to serum histamine releasing activity. Clin Exp Allergy 1997;27:14171424.
  • 74
    Sabroe RA, Fiebiger E, Francis DM, Maurer D, Seed PT, Grattan CE et al. Classification of anti-FcepsilonRI and anti-IgE autoantibodies in chronic idiopathic urticaria and correlation with disease severity. J Allergy Clin Immunol 2002;110:492499.
  • 75
    Giménez-Arnau A, Ferrer M, Hans-Jürger P, Maurer M, Pujol R. Urticaria Crónica: estudio etiológico prospectivo e importancia [Chronic Urticaria: Prospective etiologic study and autoimmune urticaria]. Actes Dermosifiliogr 2004;95:560566.
  • 76
    Tedeschi A, Lorini M, Asero R. No evidence of increased serum substance P levels in chronic urticaria patients with and without demonstrable circulating vasoactive factors. Clin Exp Dermatol 2005;30:171175.
  • 77
    Frezzolini A, Provini A, Teofoli P, Pomponi D, De Pita O. Serum-induced basophil CD63 expression by means of a tricolour flow cytometric method for the in vitro diagnosis of chronic urticaria. Allergy 2006;61:10711077.
  • 78
    Szegedi A, Irinyi B, Gal M, Hunyadi J, Danko K, Kiss E et al. Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria. Br J Dermatol 2006;155:6775.
  • 79
    Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol 2006;117:14301434.
  • 80
    Tedeschi A, Lorini M, Suli C, Asero R. Serum interleukin-18 in patients with chronic ordinary urticaria: association with disease activity. Clin Exp Dermatol 2007;32:568570.
  • 81
    Hide M, Francis DM, Grattan CE, Hakimi J, Kochan JP, Greaves MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:15991604.
  • 82
    Fagiolo U, Kricek F, Ruf C, Peserico A, Amadori A, Cancian M. Effects of complement inactivation and IgG depletion on skin reactivity to autologous serum in chronic idiopathic urticaria. J Allergy Clin Immunol 2000;106:567572.
  • 83
    Confino-Cohen R, Aharoni D, Goldberg A, Gurevitch I, Buchs A, Weiss M et al. Evidence for aberrant regulation of the p21Ras pathway in PBMCs of patients with chronic idiopathic urticaria. J Allergy Clin Immunol 2002;109:349356.
  • 84
    Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A. Assessment of histamine-releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004;34:11111114.
  • 85
    Bagenstose SE, Levin L, Bernstein JA. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. J Allergy Clin Immunol 2004;113:134140.
  • 86
    Godse KV. Autologous serum skin test in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol 2004;70:283284.
  • 87
    Gyimesi E, Sipka S, Danko K, Kiss E, Hidvegi B, Gal M et al. Basophil CD63 expression assay on highly sensitized atopic donor leucocytes-a useful method in chronic autoimmune urticaria. Br J Dermatol 2004;151:388396.
  • 88
    Reeves GE, Boyle MJ, Bonfield J, Dobson P, Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004;34:182186.
  • 89
    Pachlopnik JM, Horn MP, Fux M, Dahinden M, Mandallaz M, Schneeberger D et al. Natural anti-FcepsilonRIalpha autoantibodies may interfere with diagnostic tests for autoimmune urticaria. J Autoimmun 2004;22:4351.
  • 90
    Platzer MH, Grattan CE, Poulsen LK, Skov PS. Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients. Allergy 2005;60:11521156.
  • 91
    Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006;117:11131117.
  • 92
    Akcali C, Ozkur M, Erbagci Z, Benlier N, Aynacioglu AS. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response. J Eur Acad Dermatol Venereol 2008;22:8386.
  • 93
    Guerra L, Rogkakou A, Massacane P, Gamalero C, Compalati E, Zanella C et al. Role of contact sensitization in chronic urticaria. J Am Acad Dermatol 2007;56:8890.
  • 94
    Lourenco FD, Azor MH, Santos JC, Prearo E, Maruta CW, Rivitti EA et al. Activated status of basophils in chronic urticaria leads to interleukin-3 hyper-responsiveness and enhancement of histamine release induced by anti-IgE stimulus. Br J Dermatol 2008;158:979986.
  • 95
    Asero R, Tedeschi A, Lorini M, Caldironi G, Barocci F. Sera from patients with multiple drug allergy syndrome contain circulating histamine-releasing factors. Int Arch Allergy Immunol 2003;131:195200.